TRENDS IN NEUROSCIENCES, published by CELL PRESS, is a leading journal in the field of neuroscience, offering cutting-edge insights and important developments in the rapidly evolving landscape of brain research. With an impressive Impact Factor and ranking in the top quartile (Q1) of the category for Neuroscience (miscellaneous), it is positioned as a vital resource for researchers and professionals seeking to stay abreast of the latest discoveries and trends from 1978 to the present. Specifically ranked #3 out of 113 in General Neuroscience by Scopus, this journal promotes the interdisciplinary exchange of ideas and knowledge, making it an essential platform for students and experienced scholars alike. Although it is not an Open Access journal, its value lies in its rigorous peer-review process and commitment to maintaining the highest standards of academic integrity. By continuing to explore the complexities of neural processes and behavior, TRENDS IN NEUROSCIENCES plays a crucial role in shaping the future of neuroscience research and education.

BRAIN RESEARCH is a premier journal published by Elsevier, specializing in the intricate domains of neuroscience, developmental biology, and molecular biology. Established in 1966, this esteemed publication has become a cornerstone for researchers, professionals, and students dedicated to advancing our understanding of brain function and disorders. With an impressive impact factor and a consistent presence in the Q2 quartiles across key categories—such as Developmental Biology, Neurology, and Neuroscience—it stands out as an essential resource for disseminating innovative research and pioneering insights. The journal's scope encompasses both clinical and fundamental studies, fostering a multidisciplinary approach to the complexities of neural systems. Although it is not an open-access journal, BRAIN RESEARCH provides a vital platform for sharing progressive findings that can inspire future studies and contribute significantly to the evolutionary discourse in neuroscience. Based in the Netherlands, at RADARWEG 29, 1043 NX AMSTERDAM, BRAIN RESEARCH continues to shape the landscape of neuroscience research, inviting submissions that explore the latest discoveries and therapeutic strategies.

NEUROSCIENTIST is a leading journal in the field of clinical neurology and neuroscience, published by SAGE Publications Inc. With an impressive impact factor reflected in its Q1 quartile ranking in both clinical neurology and miscellaneous neuroscience as of 2023, this journal positions itself as a crucial platform for the latest research and advancements in the neural sciences. Spanning from 1995 to 2024, NEUROSCIENTIST features a range of high-quality, peer-reviewed articles that cater to researchers, practitioners, and students alike. Although it does not offer Open Access options, the journal remains a vital resource owing to its Scopus rankings, situating it within the top percentile of its categories: ranked #28 out of 400 in clinical neurology and #15 out of 113 in general neuroscience. The journal's commitment to disseminating significant findings underlines its importance in fostering advancements in neurological understanding and treatment.

NEUROIMMUNOMODULATION is a well-respected journal published by KARGER that focuses on the intricate interactions of the nervous and immune systems. With its ISSN 1021-7401 and E-ISSN 1423-0216, it serves as a vital resource for researchers and professionals interested in neuroimmunology and related fields. The journal has been committed to disseminating high-quality research from its inception in 1994 and continues to thrive, with its scope converged until 2024. Notably, it holds a Q3 ranking in 2023 across diverse categories such as Endocrine and Autonomic Systems, Endocrinology, Immunology, and Neurology, reflecting its significance in the scientific community. Although the journal is not open access, it remains an essential publication for advancing knowledge and fostering collaboration among scholars, making it a noteworthy source of cutting-edge findings in the complex interplay between neural and immune processes.

NEUROBIOLOGY OF DISEASE is a premier journal dedicated to advancing the understanding of neurological disorders and the underlying biological processes, published by Academic Press Inc, Elsevier Science. With an impressive impact factor indicative of its significance—ranked in the Q1 quartile in Neurology for 2023 and occupying the 14th rank out of 192 journals in the field of Neuroscience and Neurology—this journal serves as a critical resource for researchers, clinicians, and students alike. The journal has a rich history since its inception in 1994, continuously evolving its scope to encompass groundbreaking research and insights into neurobiological mechanisms and disease pathology. Though it currently does not provide Open Access options, NEUROBIOLOGY OF DISEASE remains a vital vessel for disseminating knowledge that significantly contributes to the field of neurology, fostering an understanding that can lead to innovative therapeutic strategies.

NATURE NEUROSCIENCE is a premier journal published by NATURE PORTFOLIO, focusing on cutting-edge research in the field of neuroscience. With an esteemed impact factor that reflects its significance in the academic community, this journal occupies an exceptional place in the 2023 Q1 category for neuroscience (miscellaneous) and boasts a leading Scopus rank of #1 out of 113 in general neuroscience, placing it within the top 1st percentile. Since its inception in 1998, NATURE NEUROSCIENCE has consistently delivered high-quality, peer-reviewed articles that contribute to our understanding of the nervous system, driving innovation and scholarship across disciplines. Although it does not offer open access, the journal remains a vital resource for researchers, professionals, and students seeking to stay at the forefront of neuroscientific discovery and discussion. Its editorial commitment to excellence ensures that it continually shapes the trajectory of neuroscience research well into 2024 and beyond, making it an indispensable asset for anyone passionate about the brain and its complexities.

Nature Reviews Neurology, published by NATURE PORTFOLIO, stands as a leading scholarly journal dedicated to the field of neurology and neuroscience. With an impressive impact factor and a prestigious Q1 categorization in both Cellular and Molecular Neuroscience and Clinical Neurology, this journal provides cutting-edge reviews and insights into the latest research developments, trends, and clinical practices. Based in the United Kingdom and accessible to a global audience, Nature Reviews Neurology aims to foster knowledge dissemination and interdisciplinary collaboration among researchers, healthcare professionals, and educators. With an influential Scopus ranking, it remains a pivotal resource for those seeking to deepen their understanding of neurological disorders and therapies while remaining at the forefront of academic discourse and innovation in the field.

Tissue Barriers is a pioneering journal published by Taylor & Francis Inc, specializing in the multifaceted field of tissue biology. With an Impact Factor that solidifies its stature within academia, it currently holds a Q2 ranking in Biochemistry and Cell Biology, and an esteemed Q1 ranking in Histology as per the 2023 Category Quartiles. This journal, with a history spanning from 2013 to 2024, plays a critical role in disseminating cutting-edge research that explores the intricate barriers of tissues, their functional implications in health and disease, and the molecular mechanisms behind these processes. With its notable Scopus Ranks placing it among the top journals in medicine and biochemistry, Tissue Barriers aims to foster interdisciplinary collaboration and attract submissions that contribute significantly to our understanding of tissue dynamics. This commitment to excellence in scholarly publishing makes it an essential resource for researchers, professionals, and students seeking the latest advancements in this vital area of study.

NATURE REVIEWS NEUROSCIENCE is a prestigious journal published by NATURE PORTFOLIO, renowned for its commitment to advancing the field of neuroscience. Since its inception in 2000, it has become a significant platform for disseminating comprehensive reviews and insights that shape the understanding of neurological science. With an impressive Scopus ranking of #2 out of 113 in the General Neuroscience category, this journal consistently engages the top 2% of researchers and professionals in the field, underscoring its impactful contributions. The journal not only provides a forum for high-quality reviews but also bridges emerging research trends with established knowledge, fostering a robust discourse among scholars and practitioners. As a Q1 journal in Neuroscience (miscellaneous), NATURE REVIEWS NEUROSCIENCE offers invaluable access to critical research developments, making it an essential resource for students, researchers, and professionals aiming to stay at the forefront of neuroscience advancements. Explore the latest findings and engage with a global community dedicated to unraveling the complexities of the nervous system.

GLIA is a premier journal in the fields of Cellular and Molecular Neuroscience and Neurology, published by WILEY. With an impressive track record since its inception in 1988, GLIA has become an essential resource for researchers and professionals interested in the complexities of glial cells and their roles in the nervous system. Featuring articles that encompass a wide range of topics, from basic research to clinical implications, the journal is committed to advancing our understanding of neurological functions and disorders. Although not an open access publication, GLIA maintains its reputation with a significant impact factor, consistently ranking in the Q1 category as noted in 2023 Scopus rankings. With its comprehensive scope and high-quality peer-reviewed content, GLIA serves as a vital platform for disseminating groundbreaking research in the ever-evolving landscape of neuroscience.